UNCLAIMED
Pillar Biosciences
Overview
Pillar Biosciences is a United States-based company founded in 2014 that operates within the manufacturing sector, specifically focusing on test and measurement equipment in the biotech and pharmaceuticals industries. The company employs between 51 and 200 individuals and has reported a revenue of approximately 9 million USD. Pillar Biosciences emphasizes research and development in the field of clinical diagnostics, as evidenced by their published document titled "Minimizing Sample Failure Rates for Challenging Clinical Tumor Samples," which was released in May 2023. This research article addresses the critical issue of sample failure rates in clinical settings, particularly concerning tumor samples, indicating the company's commitment to improving diagnostic accuracy and reliability. The limited document corpus suggests that Pillar Biosciences is actively engaging in research that could enhance clinical outcomes in oncology, reflecting its expertise in the intersection of biotechnology and diagnostics.